Abstract. Annexins are associated with metastasis and infiltration of cancer cells. Proteomic analysis and immunohistochemical staining were used to understand whether several annexins play important roles in cancer alone and/ or synergistically. Seven fresh breast cancer samples with 23 paraffin specimens, three fresh pancreatic samples and five fresh laryngeal carcinoma samples with 25 paraffin specimens were obtained from humans, as well as ten golden hamster pancreatic cancer tissue samples, and they were used to observe differential expression of annexins compared with normal tissues using proteomics and immunohistochemical staining. Annexin A2, A4 and A5 were overexpressed in human breast cancer and laryngeal carcinoma tissues and in golden hamster pancreatic cancer tissue samples, respectively, as shown by proteomics and immunohistochemical staining. In addition, annexin A4 and A5 were expressed in breast cancer tissues, while annexin A1 was not expressed. Annexin A1, A2 and A4 were expressed in human laryngeal carcinoma tissues as shown by immunohistochemical staining. Annexin A1, A2, A4 and A5 played important roles in breast cancer, pancreatic cancer and laryngeal carcinoma, alone and/or synergistically, and they may be targets of therapy for malignant tumors. The choice of which annexins to target should depend on their respective biological behaviors.
Introduction
The annexin family of calcium-dependent phospholipid binding proteins, as molecules that promote cancer cell invasion and metastases, play important roles in certain types of cancer, such as breast cancer, gastric cancer, esophageal carcinoma, liver cancer and nasopharyngeal carcinoma (1) (2) (3) (4) (5) . In certain cancer tissue, some annexins are upregulated but others are downregulated. Therefore, these annexins, including upregulated and downregulated members, synergistically play important roles in cancer (6, 7) . At present, studies have mainly focused on the role of single members of the annexin family in each type of cancer, but the synergistic roles that are played by several annexins are usually ignored. It is unclear whether a single annexin may play a major role in a type of cancer and other annexins minor roles.
In the physiological activity of the cells, an abundance of protein is usually associated with the strength of its effect. The different annexins may play diverse roles, so we observed them from several different common malignant tumors using differential proteomics analysis and immunohistochemical techniques to research their respective effects.
Materials and methods
Human tissue samples. Seven samples of fresh breast cancer and adjacent normal tissues (three samples from stage T1N1M0, three from T1N2M0 and one from T2N2M0) were obtained after surgery (mastectomy) in female patients aged from 35 to 65 years suffering from breast cancer, who were hospitalized in the Affiliated Hospital of North Sichuan Medical College. A total of 23 paraffin specimens of human breast infiltrating ductal carcinoma were obtained from the Department of Pathology in this hospital.
Three samples of fresh pancreatic cancer and adjacent normal tissues (two samples from T1N2M0 stage and one from T1N3M0) were obtained following surgery in male patients aged from 35 to 50 years suffering from pancreatic Annexin A1, A2, A4 and A5 play important roles in breast cancer, pancreatic cancer and laryngeal carcinoma, alone and/or synergistically cancer, who were hospitalized in the Affiliated Hospital of North Sichuan Medical College. Five groups of fresh laryngeal carcinoma and adjacent normal tissues (one sample from stage T1N1M0, two from T1N2M0, one from T1N3M0 and one from T2N2M0) were obtained following surgery (laryngectomy) in male patients aged from 45 to 60 years suffering from laryngeal carcinoma, who were hospitalized in the Affiliated Hospital of North Sichuan Medical College. A total of 25 paraffin specimens of human laryngeal squamous carcinoma were obtained from the Department of Pathology in this hospital.
These three groups of fresh samples were immediately frozen at -150˚C (Super Low Temperature Icebox, Revco, CT, USA). Care was taken to ensure that the samples were from cancer tissues with non-necrotic, non-purulent and nonhemorrhagic characteristics. Breast cancer, pancreatic cancer and laryngeal carcinoma were confirmed as infiltrating ductal carcinoma, duct adenocarcinoma and squamous carcinoma, respectively, by pathological analysis.
The research was approved by the Ethics Committee of North Sichuan Medical College and all patients voluntarily provided written informed consent to participate in the study.
Golden hamster pancreatic cancer tissue samples. In total, 127 female golden hamsters from 7 to 8 weeks of age and from 250 to 300 g in weight were purchased from the experimental animal center of North Sichuan Medical College and divided into two groups: the experimental group included 100 golden hamsters and the control group included 27 golden hamsters. The experimental group was administered BOP [N-nitroso-bis(2-oxo-propyl)amine] (C6H10N2O3, International Laboratory, San Francisco, CA, USA), which was dissolved in saline (1 mg/ml). BOP (10 mg/kg) was subcutaneously injected into the experimental group, but the control group was only injected with 1 ml saline. BOP was used once a week for a total of seven weeks and then 20 golden hamsters of the experimental group were randomly selected to undergo rosiglitazone gavage with 0.01 mg/ml and 10 ml/kg once a day for a total of five months. Finally, ten pancreatic cancer models with more than 50 mg of cancer tissue from each golden hamster were successfully obtained, and the tumors were identified as pancreatic adenocarcinoma by pathological analysis.
The experiment was performed on the condition that the use of golden hamsters followed internationally recognized guidelines on animal welfare, as well as Nanchong's and Chinese regulations.
Protein extraction. Total proteins from fresh tissues were respectively obtained with a ReadyPrep™ Protein Extraction kit (GE, Fairfield, CT, USA) and then were stored in aliquots of 200 µl at -80˚C. Concentrations of total proteins were measured with Bio-Rad RC DC Protein Assay (GE). As some substances were contained in total proteins, such as salts, nucleic acids and lipids, which may interfere with isoelectronic focusing (IEF), ReadyPrep™ Cleanup kits (GE) were used to wash them away.
Proteomics analysis. Protein samples prepared in advance were separated by two-dimensional polyacrylamide gel electrophoresis (2-DE). Isoelectronic focusing (IEF) was performed with precast IPG strips (pH 3.0-10.0, nonlinear pH IPG, 17 cm, GE) using the focusing tray (GE). For IEF, the loading volume of the protein sample was 300 µl while the loading content was 300 µg. IEF was carried out at 20˚C and 50 µA/strip. Following IEF, the strips were equilibrated, and then placed on top of the 12% SDS polyacrylamide gels prepared and sealed in place with 0.5% low-melt agarose (Sigma, St. Louis, MO, USA). The sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed at a current of 16 mA/gel for 30 min and then at another current of 24 mA/gel at 4˚C for approximately 5 h using PROTEAN II ® Xi Cell (Bio-Rad, Hercules, CA, USA). After SDS-PAGE, each gel was stained with coomassie brilliant blue R-250 (Amresco, NY, USA) and scanned with UMAXpowerlook 1120 (UMAX, Taipei, Taiwan), and then analyzed using PDQuest software (7.1) and Microsoft Office Excel 2003 to obtain differential protein spots and analyze reproducibility. Student's t-test was used for the statistical analysis of differential proteins.
Differential protein spots from gels were identified with matrix-assisted laser desorption/ionization tandem time-offlight mass tandem spectrometry (MALDI-TOF-TOF MS/MS), which was performed on an ABI 4700 TOF-TOF Proteomics Analyzer (Applied Biosystems, Foster, CA, USA). The UV laser was operated at a 200 Hz repetition rate with a wavelength of 355 nm, and the accelerated voltage was operated at 20 kV, and mass resolution was maximized at 1500 Da. Myoglobin digested with trypsin was used to calibrate the mass spectrometry instrument using the internal calibration mode, and all spectra of samples acquired were processed using 4700 Explore TM Software (Applied Biosystems) in a default mode. Finally, the data were searched by GPS Explorer (V3.6) with the search engine MASCOT 2.1, and the search parameters were as follows: the database NCBInr (NCBI2009: 9874297 sequences, 3367796496 residues), taxonomy Homo sapiens [human], protein molecular mass ranged from 700 to 3,000 Da, trypsin digest with one missing cleavage, MS tolerance was set at 0.3 Da, and MS/MS tolerance at 0.4 Da. Proteins with scores >59 or best ion scores (MS/MS) >30 were significant (P<0.05) (8) .
Immunohistochemical staining. Besides ready paraffin samples obtained from the Department of Pathology, fresh iced tissue samples were cut into small blocks (4-6 mm in length) and fixed in 10% formalin solution. After dehydration in ethanol and clearing in xylene, tissue blocks were embedded in paraffin and sectioned at 5 µm in thickness. Immunohistochemical staining was performed in three different cancer tissues including breast cancer, pancreatic cancer and laryngeal carcinoma. Ultrasensitive™ SP kits (Maixin-Bio, Fuzhou, China) were used with anti-annexin A1 antibody (Boster, Wuhan, China), anti-annexin A2 antibody (Abcam, Cambridge, UK), anti-annexin A4 antibody (BOSTER, Wuhan, China) and anti-annexin A5 antibody (Boster), respectively, as the primary antibody (dilution 1:50). The results were statistically analyzed with SPSS1 (3.0) and χ 2 test.
Results
Using PDQuest software (7. Fig. 1 and Table I ).
Furthermore, immunohistochemical staining analysis was performed to identify expression of these three annexins in the three corresponding groups of tissues, and the results show that annexin A2 (83.3%) was expressed in thirty human breast cancer tissue samples at a higher level than normal, similarly, annexin A4 (100%) was overexpressed in ten golden hamster pancreatic cancer tissue samples and annexin A5 (80.0%) was Figure 1 Three differential protein spots from 2-DE gels were identified as annexin A2, A4 and A5 (→), respectively, by differential proteomics analysis, and the proteins were individually overexpressed in human breast cancer tissues (Bca), human laryngeal carcinoma tissues (Lca) and golden hamster pancreatic cancer tissues (Pca). 2-DE, two-dimensional polyacrylamide gel electrophoresis. Lno, normal laryngeal mucosal tissues; Pno, normal pancreatic tissues; Bno, normal breast tissues. Fig. 2 and Table II) . Using human pancreatic cancer samples and adjacent normal tissues, we observed no annexins that were expressed differentially by differential proteomic analysis; however, annexin A4 was expressed in pancreatic cancer tissues at a higher level than normal in golden hamsters. By immunohistochemical staining analysis, we found that annexin A4 (70.0%) and A5 (76.7%) were expressed positively in breast cancer tissues but annexin A1 (80.0%) was negatively expressed, while annexin A1 (66.7%), A2 (80.0%) and A4 (73.3%) were positively expressed in human laryngeal carcinoma tissues (Fig. 3 and Table II) .
Discussion
In the very early stages of cancer, invasion and metastases of cancer cells often have occurred in patients prior to typical symptoms are found, and invasion and metastases of cancer cells often result in treatment failure. It was reported that invasion and metastases of cancer cells were associated with many factors, such as tumor metastasis associated gene 1 (MTA-1), matrix metalloproteinase inhibitors (TIMPs), hypoxia inducible factor 1 α (HIF-1α), nm23-H1 and annexins (9) (10) (11) (12) . Among these factors, annexins may be linked with certain signaling pathways, including cell growth, transformation and apoptosis pathways. The majority of annexins contribute to invasion and metastases of cancer cells, and every member mainly affected a type of cancer cell. Annexin A1 is related to esophageal cancer, while annexin A2 is associated with breast cancer (13, 14) . However, invasion and metastases of cancer cells are complicated biological activities and involve many important functional proteins; therefore, it is impossible that only one protein is responsible for such activities. The results indicated that proteins may synergistically affect the progression of malignant tumors.
By differential proteomics analysis, we identified that annexin A2, A4 and A5 were upregulated in breast cancer, pancreatic cancer and laryngeal carcinoma tissues, respectively, and the results indicated that a specific type of cancer cell could be affected by a specific annexin that plays a main role in a type of malignant tumor. Attention has now been drawn to whether they also play important roles in other types of cancer. According to previous studies, annexin A2 was also related to prostate cancer, invasive cervical carcinoma and lung cancer (15) (16) (17) 18) ; annexin A4 was involved in gastric cancer and colorectal cancer (2, 19) ; annexin A5 was associated with nasopharyngeal carcinoma and colorectal adenocarcinomas. The results indicated that other proteins, apart from the three annexins, may synergistically affect the progress of the three types of cancer cells. We also observed that annexin A4 and A5 were highly expressed in breast cancer tissues, while annexin A1, A2 and A4 in human laryngeal carcinoma tissues were highly expressed as shown by the immunohistochemical staining technique. These annexins were tested with immunohistochemical staining but were not found by differential proteomics analysis, and the main reason for this is that proteins of low abundance are not easy to test for due to limited sensitivity. The results displayed reveal that every member may play different roles in cancer cells, and one member may play the major role, but other members minor roles. With regard to breast cancer, annexin A2 was associated with invasion and metastases of cancer cells but annexin A4 and A5 could also contribute to tumorigenesis and the biological behavior of malignant cells. Similarly, annexin A4 and A5 affected cancer cells of pancreatic cancer and laryngeal carcinoma, respectively, while others with low abundance interfere in biological behaviors of malignant cells, but whether the specific mechanism that caused the origin and development of malignant tumors is synergistically affected by annexins is unclear.
Proliferation and invasion of breast cancer cells had decreased when annexin A2 was intercepted by RNA interference (RNAi) (21) . We also confirmed that annexin A2 was overexpressed in human breast cancer tissues but others could not be observed by differential proteomics analysis. The results showed that annexin A2 may be important in the invasion and metastasis of breast cancer cells. Although certain proteins are expressed in low abundance, we do not neglect the effects these may have on the biological activities of cells. Overexpression of annexin A4 and A5, but low annexin A1 expression, was observed by immunohistochemical staining, which showed that they functioned in cancer cells with much lower abundance. Annexin A1, which was expressed at a low level in the majority of breast carcinoma samples, was thought to enhance apoptosis (1), and result in cancer cell development and progression. Annexin A4 belongs to the annexin family, but its functions remain unclear. Overexpression of annexin A4 was observed in SCM-1 cells with H. pylori infection, which indicated that annexin A4 may be a potential novel molecular marker for gastric cancer (2) . Annexin A5 is another annexin that may be involved in apoptosis, higher tumor stage and poor prognosis, therefore it may contribute to the migration and invasion of cancer cells (20) . The results showed that development of breast cancer was a complex biological process, and annexin A1, A2, A4 and A5 synergistically play important roles in apoptosis, carcinogenesis, migration and invasion of cancer cells. Similarly, annexin A2, A4 and A5 were highly expressed in laryngeal carcinoma, which indicated that they may also contribute their respective functions to the origin and development of laryngeal carcinoma. However, annexin A1 was overexpressed in laryngeal carcinoma cells, which was different from breast cancer, and this may result from the difference between laryngeal carcinoma and breast cancer. Annexin A1 is a soluble cytoplasmic protein, moving to membranes when calcium levels are elevated. Annexin A1 was downregulated in dysplastic, tumorous and metastatic lesions, and it may progressively migrate from the nucleus towards the membrane during laryngeal tumorigenesis (22) .
Annexin A4 was reported to be upregulated in pancreatic intraepithelial neoplasia cells and may be involved in pancreatic tumor progression (23) . The annexin A group mainly exists in humans, and annexin B in animals. We found that upregulation of annexin A4 was observed in golden hamster pancreatic cancer tissues but not in humans. The results showed that annexin A4 could play different roles in golden hamster pancreatic cancer than in humans.
On the whole, malignant tumors are complex diseases, which have many factors involved. Among the annexin A group, annexin A1, A2, A4 and A5 play important roles in breast cancer, pancreatic cancer and laryngeal carcinoma, alone and/or synergistically, by regulating apoptosis, carcinogenesis, migration and invasion of cancer cells, and they may be targets of therapy for malignant tumors. The choice of which annexins to target should depend on their biological behaviors.
